CIK 0000879169 · Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943136539
- Phone
- 3024986700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,959,897
- in 5 filings, $33.0M under 10b5-1 plans
Net −$32,959,897. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Option exercise 10b5-1 | +2,864 | $77.67 | $222K | 91,705 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Option exercise 10b5-1 | +1,643 | $80.50 | $132K | 93,348 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Option exercise 10b5-1 | +3,023 | $83.20 | $252K | 96,371 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Option exercise 10b5-1 | +2,623 | $83.58 | $219K | 98,994 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Option exercise 10b5-1 | +1,642 | $85.01 | $140K | 100,636 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Option exercise 10b5-1 | +2,293 | $90.56 | $208K | 102,929 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Option exercise 10b5-1 | +85 | $106.47 | $9K | 103,014 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Option exercise 10b5-1 | +326 | $105.43 | $34K | 103,340 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Sale 10b5-1 | −14,661 | $119.46 | $1.8M | 88,679 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Sale 10b5-1 | −5,332 | $119.42 | $637K | 83,347 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Sale 10b5-1 | −2,187 | $119.47 | $261K | 81,160 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Sale 10b5-1 | −6,171 | $119.43 | $737K | 74,989 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Sale 10b5-1 | −4,695 | $119.39 | $561K | 70,294 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Sale 10b5-1 | −2,864 | $119.40 | $342K | 67,430 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Sale 10b5-1 | −1,643 | $119.51 | $196K | 65,787 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Sale 10b5-1 | −1,642 | $119.38 | $196K | 64,145 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Sale 10b5-1 | −85 | $122.19 | $10K | 64,060 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Sale 10b5-1 | −326 | $121.69 | $40K | 63,734 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Sale 10b5-1 | −2,293 | $119.41 | $274K | 61,441 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −2,918 | 1,328 |
Page 5 of 15 · 293 trades